On September 18, 2025, DarioHealth Corp. amended its preferred stock designations to accelerate conversions into common stock or pre-funded warrants, affecting Series A-1, C, C-2, D, D-1, D-2, and D-3 securities; no new securities were issued. This significant event may alter investor holdings due to upcoming mandatory conversions.